This webinar included speakers from I-ACT for Children and Aparito, the US Food and Drug Administration, the C4C pediatric site network in Europe and the MICYRN pediatric network in Canada. Clinicians detailed their firsthand experience with use of remote monitoring technology spurred by the pandemic, and the FDA’s Dr. John Alexander spoke of the agency’s efforts to provide flexibility for clinical trial researchers while maintaining focus on patient safety.